Preliminary findings of a probe initiated last year found that 2023 and 2024 revenue may have been overstated by “less than 2%” for each fiscal year, according to a Thursday
Shares in ICON fell as much as 50% on Thursday, their biggest intraday fall since March 30, 1999.
The Dublin-based company operates globally, providing clinical trials and commercialization advice to drug makers. In 2023, it announced a partnership ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
